Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Alzheimer’s disease (AD), as a neurodegenerative disorder, usually develops slowly but gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is recognized by WHO as a public health priority. Being a multifactorial disease, the origins of AD are not satisfactorily unde...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Revisão |
| Idioma: | inglés |
| Publicado: |
2023
|
| Acceso en liña: | https://doi.org/10.3390/pharmaceutics15030916 https://www.mdpi.com/1999-4923/15/3/916/pdf?version=1678689773 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|